These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. HEPATIC IRON STORAGE AND ERYTHROKINETICS AFTER PORTACAVAL SHUNT. DOBERNECK RC; MORSE AS; CONRAD ME; BERMAN AR Surgery; 1965 Jun; 57():800-8. PubMed ID: 14297954 [No Abstract] [Full Text] [Related]
5. Acute and chronic splanchnic blood flow responses to portacaval shunt in the normal dog. Gurll NJ; Reynolds DG; Coon D; Shirazi SS Gastroenterology; 1980 Jun; 78(6):1432-6. PubMed ID: 7372063 [TBL] [Abstract][Full Text] [Related]
6. The development of postshunt hemochromatosis--parenchymal siderosis in patients with cirrhosis occuring after portasystemic shunt surgery. A review of the literature and report of two additional cases. Ecker JA; Gray PA; McKittrick JE; Dickson DR Am J Gastroenterol; 1968 Jul; 50(1):13-29. PubMed ID: 5662506 [No Abstract] [Full Text] [Related]
7. An attempt to decrease ammonia levels after portacaval anastomosis in dogs: hepatic periarterial neurectomy. Yilmaz S; Kirimlioglu V; Katz D; Basak K; Caglikulekci M; Kayaalp C; Yildirim B; Akoglu M Dig Dis Sci; 2002 Sep; 47(9):1943-52. PubMed ID: 12353834 [TBL] [Abstract][Full Text] [Related]
9. Factors influencing hemosiderosis. The role of iron absorption. Doberneck RC Am J Surg; 1971 Jul; 122(1):33-5. PubMed ID: 5091851 [No Abstract] [Full Text] [Related]
10. Hepatic morphologic changes following end-to-side portacaval shunt in dogs. Lanier VC; Buchanan RD; Foster JH Am Surg; 1968 Mar; 34(3):185-95. PubMed ID: 5638502 [No Abstract] [Full Text] [Related]
11. Effect of cyclosporine on hepatic energy status and on fructose metabolism after portacaval shunt in dog as monitored by phosphorus-31 nuclear magnetic resonance spectroscopy in vivo. Rossaro L; Mazzaferro V; Scotti-Foglieni CL; Williams DS; Simplaceanu E; Simplaceanu V; Francavilla A; Starzl TE; Ho C; Van Thiel DH Hepatology; 1991 Apr; 13(4):780-5. PubMed ID: 2010174 [TBL] [Abstract][Full Text] [Related]
12. Effect of portacaval shunt and arterialization of the liver on bile acid metabolism. Horak W; Gangl A; Funovics J; Grabner G Gastroenterology; 1975 Aug; 69(2):338-41. PubMed ID: 1150042 [TBL] [Abstract][Full Text] [Related]
13. Effect of portacaval shunt on the disposition of drugs with and without first-pass effect. Gugler R; Lain P; Azarnoff DL J Pharmacol Exp Ther; 1975 Dec; 195(3):416-23. PubMed ID: 1195128 [TBL] [Abstract][Full Text] [Related]
16. Site of origin of the hormone responsible for gastric hypersecretion associated with portacaval shunt. Orloff MJ; Villar-Valdes H; Abbott AG; Williams RJ; Rosen H Surgery; 1970 Jul; 68(1):202-7; discussion 207-8. PubMed ID: 10483470 [TBL] [Abstract][Full Text] [Related]
17. The "H-graft" in portacaval shunt in dogs. Grga A; Maticić Z; Hlevnjak D; Hofman B Mater Med Pol; 1994; 26(3):109-12. PubMed ID: 7603080 [TBL] [Abstract][Full Text] [Related]
18. Experimental, clinical, and metabolic results of side-to-side portacaval shunt for intractable cirrhotic ascites. Orloff MJ; Orloff MS; Orloff SL; Girard B J Am Coll Surg; 1997 Jun; 184(6):557-70. PubMed ID: 9179111 [TBL] [Abstract][Full Text] [Related]
19. Decarboxylation to tyramine: an important route of tyrosine metabolism in dogs with experimental hepatic encephalopathy. Faraj BA; Ali FM; Ansley JD; Malveaux EJ Gastroenterology; 1978 Dec; 75(6):1041-4. PubMed ID: 710855 [TBL] [Abstract][Full Text] [Related]
20. Arterialization of the liver in combination with a portacaval shunt in the dog. Adamsons RJ; Arif S; Babich A; Butt K; Lam A; Minkowitz S Surg Gynecol Obstet; 1975 Apr; 140(4):594-600. PubMed ID: 1129667 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]